Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity’s ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality and artificial intelligence, MindMaze has enhanced the recovery potential of patients with neurological diseases.

Combining FDA cleared and CE marked digital therapeutics with best-in-class motion analytics, AI and cloud technologies, MindMaze aims to create the universal platform for brain health.

MindMaze Labs is the R&D division bringing ground-breaking neuroscience to everyday life, empowering the next generation of human-machine interfaces through advanced neuroscience, deep tech, and innovative engineering.

MindMaze Healthcare focuses on FDA and CE cleared digital therapeutics creating solutions for neurorehabilitation.

MindMaze Labs serves as a deep tech R&D hub focused on improving various aspects of life beyond healthcare.

Over the years, MindMaze has transformed care for neurological diseases through novel digital therapies, pioneering neurorehabilitation products, and expansion into international markets including the US and China.

Notable achievements include multiple patents, funding rounds, strategic partnerships with leading health systems, and development of innovative neurotechnology peripherals.